• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲氨蝶呤一日疗法与八日疗法治疗低危妊娠滋养细胞肿瘤的有效性和效率比较

Effectiveness and Efficiency Comparison of One-Day vs Eight-Day Methotrexate Protocols in Managing Low-Risk Gestational Trophoblastic Neoplasia.

作者信息

Agbari Vidiatma, Hidayat Yudi Mulyana, Kurniadi Andi, Salima Siti, Harsono Ali B, Suardi Dodi, Yuseran Hariadi, Lisnasari Desy

机构信息

Department of Obstetrics and Gynecology, Faculty of Medicine, Padjadjaran University, Dr Hasan Sadikin General Hospital Bandung, Bandung, West Java, Indonesia.

Department of Obstetrics and Gynecology, Faculty of Medicine, Lambung Mangkurat University, Ulin Regional General Hospital, Banjarmasin, South Kalimatan, Indonesia.

出版信息

Int J Womens Health. 2024 Dec 3;16:2077-2085. doi: 10.2147/IJWH.S486620. eCollection 2024.

DOI:10.2147/IJWH.S486620
PMID:39649071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11625181/
Abstract

BACKGROUND

Gestational Trophoblastic Neoplasia (GTN) has a high incidence in Bandung, Indonesia, with a mortality rate between 31% and 51%. The most common type is low-risk GTN with various treatment protocols available. The 8-day Methotrexate (MTX) 50 mg protocol has been implemented at our center; however, due to limitation of government insurance, this study aims to compare its effectiveness against the 1-day Methotrexate (MTX) 300 mg/m² protocol.

METHODS

A retrospective cohort study compared two protocols for low-risk GTN treatment at Dr. Hasan Sadikin General Hospital from January 2020 to December 2023: a 1-day Methotrexate (MTX) 300 mg/m² protocol and an 8-day MTX protocol (50 mg MTX IM on days 1, 3, 5, 7 with folinic acid 15 mg orally 24 h after MTX on days 2, 4, 6, 8) and repeat every 2 weeks. Data on patient characteristics, chemotherapy response, side effects, and treatment costs were analyzed.

RESULTS

The 1-day MTX 300 mg/m² protocol achieved similar remission with fewer cycles, milder side effects, and reduced costs compared to the 8-day MTX 50 mg protocol, supporting it as an effective treatment option for low-risk GTN.

CONCLUSION

The 1-day MTX 300 mg/m² protocol is as an effective treatment option for low-risk GTN compared to the 8-day MTX 50 mg protocol.

摘要

背景

妊娠滋养细胞肿瘤(GTN)在印度尼西亚万隆的发病率很高,死亡率在31%至51%之间。最常见的类型是低风险GTN,有多种治疗方案可供选择。我们中心已实施8天的甲氨蝶呤(MTX)50毫克方案;然而,由于政府保险的限制,本研究旨在比较其与1天的甲氨蝶呤(MTX)300毫克/平方米方案的有效性。

方法

一项回顾性队列研究比较了2020年1月至2023年12月在哈桑·萨迪金综合医院治疗低风险GTN的两种方案:1天的甲氨蝶呤(MTX)300毫克/平方米方案和8天的MTX方案(第1、3、5、7天肌肉注射MTX 50毫克,第2、4、6、8天在MTX后24小时口服亚叶酸15毫克),每2周重复一次。分析了患者特征、化疗反应、副作用和治疗费用的数据。

结果

与8天的MTX 50毫克方案相比,1天的MTX 300毫克/平方米方案在更少的周期内实现了相似的缓解,副作用更轻,成本更低,支持其作为低风险GTN的有效治疗选择。

结论

与8天的MTX 50毫克方案相比,1天的MTX 300毫克/平方米方案是低风险GTN的有效治疗选择。

相似文献

1
Effectiveness and Efficiency Comparison of One-Day vs Eight-Day Methotrexate Protocols in Managing Low-Risk Gestational Trophoblastic Neoplasia.甲氨蝶呤一日疗法与八日疗法治疗低危妊娠滋养细胞肿瘤的有效性和效率比较
Int J Womens Health. 2024 Dec 3;16:2077-2085. doi: 10.2147/IJWH.S486620. eCollection 2024.
2
Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.一线甲氨蝶呤化疗治疗低危绒癌的有效性和毒性:新英格兰滋养细胞疾病中心的经验。
Gynecol Oncol. 2018 Jan;148(1):161-167. doi: 10.1016/j.ygyno.2017.10.028. Epub 2017 Oct 29.
3
Comparison of weekly methotrexate regimen versus methotrexate folinic acid 8-day regimen for treatment of low-risk gestational trophoblastic neoplasia.低危型妊娠滋养细胞肿瘤每周甲氨蝶呤方案与甲氨蝶呤-亚叶酸钙 8 天方案的疗效比较。
Asia Pac J Clin Oncol. 2022 Jun;18(3):326-332. doi: 10.1111/ajco.13623. Epub 2021 Jun 29.
4
Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemotherapy on the weekend.比较低危 GTN 采用标准 8 天 MTX/FA 方案与周末无化疗的改良 MTX/FA 方案的治疗效果。
Gynecol Oncol. 2020 Mar;156(3):598-605. doi: 10.1016/j.ygyno.2019.12.044. Epub 2020 Jan 10.
5
Folinic acid rescue during methotrexate treatment for low-risk gestational trophoblastic neoplasia - How much is just right?氨甲喋呤治疗低危妊娠滋养细胞肿瘤时用亚叶酸钙解救——多少才合适?
Gynecol Oncol. 2021 Sep;162(3):638-644. doi: 10.1016/j.ygyno.2021.07.013. Epub 2021 Jul 13.
6
Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.每周使用甲氨蝶呤(50mg/m(2)),不进行剂量递增,作为低危妊娠滋养细胞肿瘤的主要治疗方案。
Gynecol Oncol. 2010 Jun;117(3):477-80. doi: 10.1016/j.ygyno.2010.02.029. Epub 2010 Mar 29.
7
Folic acid versus folinic acid during methotrexate treatment for low-risk gestational trophoblastic neoplasia.甲氨蝶呤治疗低危妊娠滋养细胞肿瘤期间叶酸与亚叶酸的比较
Ginekol Pol. 2025;96(3):200-205. doi: 10.5603/gpl.101142. Epub 2025 Feb 4.
8
Comparison of Cost-Effectiveness Between Actinomycin D Versus Methotrexate-Folinic Acid in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia.放线菌素D与甲氨蝶呤-亚叶酸在治疗低危妊娠滋养细胞肿瘤中的成本效益比较
J Reprod Med. 2016 May-Jun;61(5-6):230-4.
9
Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women.巴西女性中低风险妊娠滋养细胞肿瘤的治疗:双周8天甲氨蝶呤联合亚叶酸与大剂量放线菌素D的比较
Rev Bras Ginecol Obstet. 2015 Jun;37(6):258-65. doi: 10.1590/SO100-720320150005366.
10
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study.在治疗低危妊娠滋养细胞肿瘤的 8 天 MTX/FA 方案中,甲氨蝶呤(MTX)剂量是否会影响结局?MITO-9 研究。
Gynecol Oncol. 2018 Dec;151(3):449-452. doi: 10.1016/j.ygyno.2018.09.025. Epub 2018 Sep 26.

本文引用的文献

1
Resistance to single-agent chemotherapy in low-risk gestational trophoblastic neoplasia.低危妊娠滋养细胞肿瘤对单药化疗的耐药性。
Caspian J Intern Med. 2023 Winter;14(1):47-52. doi: 10.22088/cjim.14.1.47.
2
Flat-dose versus weight or body surface area-based methotrexate dosing in low-risk gestational trophoblastic neoplasia.低危型妊娠滋养细胞肿瘤中基于固定剂量与体质量或体表面积的甲氨蝶呤剂量。
Gynecol Oncol. 2023 Feb;169:34-40. doi: 10.1016/j.ygyno.2022.11.025. Epub 2022 Dec 7.
3
Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia.甲氨蝶呤给药方式的差异及其对低危妊娠滋养细胞肿瘤结局的影响
Cancers (Basel). 2022 Feb 8;14(3):852. doi: 10.3390/cancers14030852.
4
Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: A Society of Gynecologic Oncology evidenced-based review and recommendation.妊娠滋养细胞疾病的流行病学、诊断与治疗:妇科肿瘤学会循证综述与推荐
Gynecol Oncol. 2021 Dec;163(3):605-613. doi: 10.1016/j.ygyno.2021.10.003. Epub 2021 Oct 20.
5
Challenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia.低危妊娠滋养细胞肿瘤治疗中的挑战
Rev Bras Ginecol Obstet. 2021 Jul;43(7):503-506. doi: 10.1055/s-0041-1735177. Epub 2021 Aug 30.
6
Chemotherapy initiation with single-course methotrexate alone or combined with dactinomycin versus multi-course methotrexate for low-risk gestational trophoblastic neoplasia: a multi-centric randomized clinical trial.单疗程甲氨蝶呤单独使用或联合放线菌素D与多疗程甲氨蝶呤用于低危妊娠滋养细胞肿瘤的化疗起始治疗:一项多中心随机临床试验。
Front Med. 2022 Apr;16(2):276-284. doi: 10.1007/s11684-021-0855-4. Epub 2021 Jun 28.
7
Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.一线甲氨蝶呤化疗治疗低危绒癌的有效性和毒性:新英格兰滋养细胞疾病中心的经验。
Gynecol Oncol. 2018 Jan;148(1):161-167. doi: 10.1016/j.ygyno.2017.10.028. Epub 2017 Oct 29.
8
First-line chemotherapy in low-risk gestational trophoblastic neoplasia.低危妊娠滋养细胞肿瘤的一线化疗
Cochrane Database Syst Rev. 2016 Jun 9;2016(6):CD007102. doi: 10.1002/14651858.CD007102.pub4.
9
Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.甲氨蝶呤输注和亚叶酸作为非转移性和低风险转移性妊娠滋养细胞肿瘤的一线治疗:15年经验
J Reprod Med. 2002 May;47(5):355-62.
10
Methotrexate infusion in low-risk gestational trophoblastic disease.低风险妊娠滋养细胞疾病的甲氨蝶呤输注
Am J Obstet Gynecol. 2000 Dec;183(6):1579-82. doi: 10.1067/mob.2000.108077.